Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-060380
Filing Date
2025-06-17
Accepted
2025-06-17 21:33:41
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518182-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2518182-5_3seq1.xml 3 4176
2 EXHIBIT 24 tm2518182d5_ex24.htm EX-24 9474
  Complete submission text file 0001104659-25-060380.txt   15163
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Issuer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 750 W. JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address
Denton John Russel (Reporting) CIK: 0002071923 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42706 | Film No.: 251055021